Translating membrane proteins into therapeutics; from bedside to bench

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/1150083

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Membrane proteins are the principal gatekeepers for control of cellular response, with G protein-coupled receptors (GPCRs) the largest family of cell surface proteins. These proteins are critically important for pathophysiological control, and are a major target for drug discovery. Nonetheless drug attrition due to lack of clinical efficacy remains high. We are combining cell biology, clinical management and drug discovery science to enable more effective therapeutic translation.

Funded Activity Details

Start Date: 01-01-2019

End Date: 01-01-2023

Funding Scheme: Program Grants

Funding Amount: $9,466,000.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Basic Pharmacology

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

G protein-coupled receptors | cell signalling | membrane lipids | membrane protein | schizophrenia and related disorders

Related Links